Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The 5 Ms: A Simple Framework to Care for Older Patients

Samantha C. Shapiro, MD  |  December 5, 2024

Adobe Stock | Rido

Adobe Stock | Rido

WASHINGTON, D.C.—For the first time in U.S. history, older adults are projected to outnumber children by 2034, and their care poses unique challenges to the rheumatologist.1 Normal physiologic changes of aging include but aren’t limited to falling renal function, changes in pharmacokinetics and bone density loss.

Dr. Namrata Singh

Dr. Namrata Singh

At the ACR Convergence 2024 Review Course, Namrata Singh, MD, MSCI, FACP, assistant professor, Division of Rheumatology, University of Washington, Bellevue, provided a framework that we can use to think about and care for our geriatric patients called The 5 Ms.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Geriatric Syndromes, Multimorbidity & Polypharmacy

Dr. Singh kicked off her talk with some important definitions that help us better understand geriatric care.

Geriatric syndromes are clinical conditions in older people that don’t fit into disease categories but are highly prevalent in older age, multifactorial, and associated with multiple comorbidities and poor outcomes. Examples include frailty, delirium, falls, visual impairment, social isolation, immobility, sarcopenia and dementia.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Multimorbidity is defined as the concurrent existence of more than one medical condition in the same individual. It’s a broader concept than comorbidity. Comorbidity centers on an index condition, such as rheumatoid arthritis (RA), with other conditions (e.g., osteoporosis and cardiovascular disease) circling around it. Multimorbidity, on the other hand, puts the patient at the center.3

Polypharmacy, defined as the concurrent use of five or more medications, can be particularly dangerous for older patients and is common in people with rheumatic disease. Numbers aren’t the enemy, explained Dr. Singh. Unnecessary, ineffective and harmful prescribing is.

Polypharmacy often results from prescribing cascades, in which additional medications are prescribed to treat the adverse effects of previously prescribed medications, effects that are misdiagnosed as a new medical condition.4 For example, a patient with arthritis is prescribed ibuprofen, which results in hypertension, which is treated with a calcium channel blocker, which causes ankle swelling, which is treated with a diuretic, which causes gout, which is treated with allopurinol. See how one medication suddenly devolves into four?

Adobe Stock | Akarawut

Adobe Stock | Akarawut

Geriatric syndromes, multimorbidity and polypharmacy are interconnected via multidirectional relationships and synergistic interactions. So to truly care for our older patients comprehensively, we need to take the whole ecosystem into account.5

The 5 Ms

If the concepts above felt like a lot, join the club. There are a lot of moving pieces to consider when caring for older patients, and it all can feel overwhelming, especially in the context of a 15- to 20-minute follow-up visit. Dr. Singh invited us all to take a deep breath as she introduced a tool that can help: The 5 Ms—multicomplexity, mind, mobility, medications and “what matters most.”6

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024elder care

Related Articles

    Tackling Multicomplexity in Aging Patients with RA

    November 22, 2021

    Two sessions at ACR Convergence 2021 addressed a holistic approach to taking care of older patients with RA & other rheumatic diseases.

    As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

    November 1, 2012

    Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

    Optimizing DMARD Use in Older Adults with Rheumatoid Arthritis

    April 10, 2024

    SAN DIEGO—Older adults with rheumatoid arthritis (RA) comprise two groups: those who have lived with diagnosed RA since an early age (young-onset RA) and those who have new-onset RA diagnosed at an older age (≥65 years), known as late-onset RA or, formerly, as elderly onset RA.1 Individuals with late-onset RA have more acute and systemic…

    How to Optimize Treatment for Aging Patients with Rheumatic Conditions

    August 30, 2023

    As patients with rheumatic musculoskeletal disease age, the number of medications they take may increase (i.e., polypharmacy), which can result in unwanted side effects and serious adverse effects. Lee et al. offer considerations and insights into caring for aging patients in a polypharmacy situation to better meet their health and lifestyle needs.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences